Indi a Ste m Ce lls Ma rke t Fore ca st & O pport uni t i e s , 2020

P h a r m a & H e a l t h c a r e C o n s u l t a n t s

I n d u s t r y B r i e f

2

© Pharmaion

India Stem Cells Market to Grow at 28% through 2020

Growing presence of stem cells research centres, increasing consumer awareness and rising medical tourism isdriving Indian stem cells market

According to recently published Pharmaion report, “India Stem Cells Market Forecast & Opportunities,2020”, stem cells market in India is anticipated to grow at a CAGR of over 28% over 2015 - 2020. Growth inthe market is anticipated on account of increasing investments from the government as well as various privateorganizations, growing industry focus on stem cell research, and rising awareness about stem cell banking.Moreover, emergence of induced pluripotent stem (iPS) cells as an alternative to embryonic stem cells (ESCs),and evolution of new stem cell therapies are anticipated to boost growth in stem cells market in India over thenext five years.

Being considered as the “building blocks of life”, stem cells are capable of treating various diseases, such asdiabetes, multiple sclerosis, Parkinson's, Alzheimer's, arthritis, blindness, stroke and heart diseases. Moreover,scientists across the country are working on techniques to further enhance the efficacy of stem cell therapy. Forinstance, menstrual stem cell technology is a budding trend, which is capable of growing heart muscles at asuccess rate of more than 100 times higher than the 0.2-0.3% for stem cells taken from bone marrow. Thesecells can revolutionise the way many diseases are being treated and transform the lives of millions of peopleacross the country in the coming years.

On the basis of services offered, India stem cells market has been segmented into two categories, namely, stemcell banking and stem cell research. Stem cell research dominated the market in 2014, and is anticipated tocontinue its dominance during 2015 - 2020 on account of growing focus on commercialization of public andprivate research, rising number of stem cell research groups, and escalating cost for traditional drugdevelopment. In 2014, adult stem cells accounted for a majority share in the India stem cells market owing to alarge number of research being carried out using adult stem cells.

“Private stem cell banks are adopting various marketing tactics in order to increase their product visibility acrossthe country. Sales force of these private firms are visiting consumers and educating them about stem cellbanking concepts and associated advantages. Moreover, in India, the stem cell industry is witnessing increasinglevel of collaborations among the various stakeholders, which is positively impacting the stem cells market in thecountry.” said Mr. Karan Chechi, Research Director with Pharmaion, a research based global pharmaceutical andhealthcare consulting firm.

T a b l e o f C o n t e n t s

3

S No. Contents

1. Research Methodology

2. Analyst View

3. Product Overview

4. Global Stem Cell Market Overview

5. India Stem Cell Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Services

5.2.2. By Type

5.2.3. By Region

5.2.4. By Ownership

6. India Stem Cell Research Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Type

7. India Stem Cell Banking Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Type

© Pharmaion

T a b l e o f C o n t e n t s

4

S No. Contents

8. Market Dynamics

8.1. Drivers

8.2. Challenges

9. Market Trends & Developments

9.1. Medical Tourism

9.2. Dental Stem Cell Banking

9.3. Menstrual Blood Stem Cell Banking

9.4. New Marketing Concepts

9.5. Collaborations & Partnerships

10. SWOT Analysis

11. Policy & Regulatory Landscape

12. India Economic Profile

13. Competition Landscape

13.1. Competition Matrix

13.2. Company Profiles

13.2.1. LifeCell International Pvt. Ltd

13.2.2. Reliance Life Sciences Pvt. Ltd.

13.2.3. Cryobanks International India Pvt. Ltd.

13.2.4. CordLife Sciences India Pvt. Ltd.

13.2.5. Cryo-Save (India) Private Limited

13.2.6. Stemade Biotech Pvt. Ltd.

13.2.7. Institute for Stem Cell Biology and Regenerative Medicine (inStem)© Pharmaion

T a b l e o f C o n t e n t s

5

S No. Contents

13.2.8. Nichi-In Centre for Regenerative Medicine

13.2.9. TranScell Biologics Pvt. Ltd.

13.2.10. EmProCell Clinical Research Private Limited

14. Strategic Recommendations

15. About Us & Disclaimer

© Pharmaion

R e s e a r c h M e t h o d o l o g y

6

Baseline Methodology:

For the study, Pharmaion has gathered information through primary research with respondents in stem cell banking

and research companies across India, followed by external validation of the information by interviewing

distributors. We also gathered insights through exhaustive search of credible paid databases and our internal

database. Our team of analysts has then prudently evaluated all the collected information and presented it in

chronological order to depict a meaningful and comprehensible picture of India stem cells market.

While compiling the data, we have also validated all the collected information from multiple sources and data

warehouses, in order to present accurate and precise information of the concerned industry. The same information

has then been verified through primary research surveys with competitors to arrive at logical figures.

Manufacturers Interviewed

Nichi-In Centre for Regenerative Medicine, LifeCell International Pvt. Ltd., Reliance Life Sciences Pvt. Ltd., L V

Prasad Eye Institute, inStem, Cryobanks International India Pvt. Ltd., EmProCell Clinical Research Private Limited,

TranScell Biologics PVT.,LTD.

Sources: Company Websites, The National Apex Committee for Stem Cell Research and Therapy (NAC-SCRT),

Indian Council of Medical Research (ICMR) and Department of Biotechnology (DBT)

© Pharmaion

S a m p l e D a t a - S n a p s h o t

7

© Pharmaion

13

57

913

1517

1921 23

2010 2011 2012 2013 2014 2015E2016F2017F2018F2019F2020F

India Stem Cells Market Size, By

Value, 2010-2020F (USD Million)

38.00%38.10%38.20%38.30%38.40%38.50%38.60%38.70%38.80%38.90%39.00%

60.00%60.10%60.20%60.30%60.40%60.50%60.60%60.70%60.80%60.90%61.00%

2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F

Stem Cell Banking Stem Cell Research

India Stem Cells Market Share, By Service, By Value, 2010-2020F

Hematopoietic & Bone Marrow,

10%

Neuronal, 10%

Mesenchymal, 10%

Liver, 10%

Pancreatic Progenitor Cells, 10%

Limbal, 10%

Cardiac, 10%

Retinal, 10%

Muscle, 10% Cancer, 10%

India Adult Stem Cells Market

Share, By Type, By Value, 2014

3.00% 3.10% 3.20% 3.30% 3.40% 3.50% 3.60% 3.70% 3.80% 3.90% 4.00%

28.00%28.10%28.20%28.30%28.40%28.50%28.60%28.70%28.80%28.90%29.00%

30.00%30.10%30.20%30.30%30.40%30.50%30.60%30.70%30.80%30.90%31.00%

33.00%33.10%33.20%33.30%33.40%33.50%33.60%33.70%33.80%33.90%34.00%

2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F

South

West

North

Others

India Stem Cells Market Share, By Region, By Value, 2010-2020F

Average Cost of Stem Cell Banking

in India (USD)

Cord Stem Cell Banking

X

Dental Stem Cell Banking

X

Bone Marrow Stem Cell Banking

X

Menstrual Blood Stem Cell Banking

X

Adipose Tissue Stem Cell Banking

X

India Stem Cells Banking Market Size, By

Value, 2010-2020F (USD Million)

13

57

913

1517

1921

23

2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F

Indicators India

Diabetes cases X (million) X

Undiagnosed diabetes cases X

(million)X

Diabetes national prevalence (X%) X

Diabetes comparative prevalence

(X%)X

Diabetes related deaths X (million) X

Cost/person with diabetes (X) X

India Summary of Diabetes Indicators, 2014

R e p o r t O r d e r i n g

8

© Pharmaion

License Type Price

Single User License $3000

Single User License Print $3500

Enterprise License $6000

To View Sample OR Purchase Report

Report Price

Report Name: India Stem Cells Market Forecast and

Opportunities, 2020

A b o u t U s & D i s c l a i m e r

9

© Pharmaion

NORTH AMERICA

Pharmaion Consultants LLC

708 3RD Avenue, 6th Floor, New York, NY,

United State, 10017

sales@pharmaion.com

+1 646 360 1656

www.pharmaion.com

About Us :

Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry.

Pharmaion’s core values are value, integrity and insight. Led by a team of dynamic industry experts, Pharmaion provides its customers

with high value market research and advisory services that helps them identify new market opportunities, growth engines andinnovative ways to capture the market share. As a result, Pharmaion’s clients lead rather than follow market trends. Not bound bylegacy, Pharmaion’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as

engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, Pharmaion’s reportsdo not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.

Pharmaion is committed to assisting customers worldwide with their unique market research needs by providing them withcomprehensive, value-added solutions and professional market intelligence services. Pharmaion employs the industry’s best-trained

industry Analysts and Consultants, which advises and assists customers in meeting their full service market research and consultingrequirements.

Related Reports

India Hospitals Market Forecast & Opportunities, 2020

Global Tissue Engineered Medical Devices Market Forecast & Opportunities, 2020

Global Cervical Cancer Vaccine Market Forecast & Opportunities, 2020

Disclaimer :The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is madethat it is timely, accurate or complete. Pharmaion Consultants has taken due care and caution in compilation of data as this has been obtained fromvarious sources including which it considers reliable and first hand. However, Pharmaion Consultants does not guarantee the accuracy, adequacy orcompleteness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information andespecially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimatesand forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’sinternal consumption. Usage of the same for purpose other than internal will require prior approval of Pharmaion Consultants.

ASIA-PACIFIC

Pharmaion Consultants Pvt. Ltd.

A – 51, Sector 57, Noida, National Capital Region,

India - 201301

sales@pharmaion.com

+91 - 120 - 452 3900

www.pharmaion.com